Back to Rheumatology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Lupus

Overview

Spherix’s coverage of the systemic lupus erythematosus market focuses on rheumatologists’ understanding, diagnosis, and treatment of the disease. Learnings include brand use, factors in brand selection and criteria for evaluating success.

Services Available

Trending market evolution

  • Lupus Nephritis (US)

Service Info

RealTime Dynamix™ is an independent service providing strategic guidance through quarterly or semiannual reports, which include market trending and a fresh infusion of event-driven and variable content with each wave. The reports provide an unbiased view of the competitive landscape within rapidly evolving specialty markets, fueled by robust HCP primary research and our in-house team of experts.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

US: quarterly report (n=100-200 respondents)

EU5: semiannual report (n=250 respondents)

Canada: semiannual report (n=50 respondents)

Exploring the patient journey

  • Lupus Nephritis (US)

  • Moderate to Severe Systemic Lupus Erythematosus (US)

  • Moderate to Severe Systemic Lupus Erythematosus (EU)

Service Info

RealWorld Dynamix™ is an independent, data-driven service unveiling real patient management patterns through rigorous analysis of large-scale patient chart audits. Insights reveal the “why” behind treatment decisions, include year over year trending to quantify key aspects of market evolution, and integrate specialists’ attitudinal & demographic data to highlight differences between stated and actual treatment patterns.

Report Methodology: Insights are based on patient level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with their rationale for treatment choices.

Sample Size and Frequency

US: annual patient chart audit (n=1,000 charts, n=200 physicians)

EU5: annual patient chart audit (n=1,250 charts, n=250 physicians)

Prepping for the pipeline

  • Systemic Lupus Erythematosus (US)

  • Systemic Lupus Erythematosus (EU)

Service Info

Market Dynamix™ is an independent service providing analysis of markets anticipated to experience a paradigm shift within the next three to five years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents and select KOLs.

Sample Size and Frequency

Annual report (n=100-200 physicians)

Qualitative interviews (n=6-8 physicians, n=2-3 KOLs)

Benchmarking new brand performance

  • Benlysta (GSK) and Lupkynis (Aurinia) in Lupus Nephritis (US)

  • Saphnelo (AstraZeneca) in Systemic Lupus Erythematosus (US)*

*Pending approvals and launch

Service Info

Launch Dynamix™ is an independent service providing monthly benchmarking of newly launched products for the first eighteen months of commercial availability, augmented by a quarterly deep dive into promotional activity, barriers to uptake, and patient types gravitating to the launch brand.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of physicians “in the trenches” recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents.

Sample Size and Frequency

Monthly KPI benchmarking (n=75 physicians)

Quarterly report (n=75 physicians)

Quarterly qualitative interviews (n=8 physicians)

gauging impact of disruptive events

  • Multi Specialty Impact of COVID 19 Rheumatology (US)

  • Rheumatology Biosimilars Today and Tomorrow (US)

  • Fellows and Residents (US)

Service Info

Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

Report cadence and deliverable depend upon current event/topic being evaluated.

Learn more about our services

HOW CAN WE PARTNER TOGETHER?

Get more information on Lupus Coverage